+ + data and comment + +, page-6

Extract from Announcement:

"With the market for analgesics to treat neuropathic pain estimated at several billion dollars, an effective therapy could potentially reap similar rewards to the blockbuster COX-2-selective anti-inflammatory analgesics - such as Celebrex - which are
currently serving the arthritis pain market".


No wonder they are in a big hurry. That should strengthen the pipeline.

Gerry
Please do your own research and you decide if and when to buy, hold or sell any stocks.